BluGlass placement to leading technology focused micro-cap fund to raise A$2 million
BluGlass entitlement offer of approximately A$6 million to provide capital to expedite laser diode opportunity and enable ongoing execution of business strategy
Entitlement offer priced and structured to encourage broad shareholder participation
Issue price of placement and entitlement offer of $0.03 represents a 47.5% discount to the Company’s 15 day VWAP to 7 June 2021 of $0.0571
Directors and key executives to take up full entitlement under the entitlement offer
BluGlass Limited (ASX:BLG) (BluGlass or Company) announces today a non-renounceable entitlement offer on a 1 for 4 basis (Entitlement Offer) to holders of ordinary shares in the Company (Shareholders) held at 7:00pm (Sydney time) on 15 June 2021 (Record Date).
BluGlass is also undertaking a private placement of 66,666,667 new fully paid ordinary shares (New Shares) to raise $2 million at an issue price of $0.03 per New Share (Placement). The New Shares to be issued under the Placement will be issued to a leading technology focused fund and are intended to be issued on or around 11 June 2021 and will be eligible to participate in the Entitlement Offer.
The Entitlement Offer will be offered to those Shareholders who are registered as a holder of ordinary shares in the Company as at the Record Date with a registered address in Australia, New Zealand and certain other jurisdictions in which the Company has decided to extend the Entitlement Offer and are not in the United States (Eligible Shareholders). Eligible Shareholders will receive an Entitlement Offer booklet (Offer Booklet) including a personalised entitlement and acceptance form which will provide further details of how to participate in the Entitlement Offer. A copy of the Offer Booklet will be lodged with the ASX on 9 June 2021 and available on the ASX website.
The Offer Booklet will be dispatched to Eligible Shareholders on or before 16 June 2021.
Details of the Entitlement Offer
Pursuant to the Entitlement Offer, the Company will issue up to 197,333,333 New Shares to raise approximately A$6 million (before costs). The New Shares will rank equally with existing ordinary shares in the Company. Under the Entitlement Offer, Eligible Shareholders will be invited to subscribe for 1 New Share for every 4 ordinary shares held by them at the Record Date. Fractional entitlements will be rounded up to the next whole New Share. BluGlass Directors and its key executives intend to take up their full entitlement under the Entitlement Offer.
The issue price per New Share of $0.03 (Issue Price) represents a 46.4% discount to the Company’s last close of $0.056 on 4 June 2021, and a 47.5% discount to the Company’s 15 day VWAP to 7 June 2021 of $0.0571. The Company will make an application to the ASX for the official quotation of the New Shares.
The Entitlement Offer is being conducted under section 708AA of the Corporations Act 2001 (Cth) as notionally modified by ASIC Corporations (Non-Traditional Rights Issues) Instrument 2016/84 and does not require a prospectus or other disclosure document.
Entitlements are non-renounceable and will not be tradeable on ASX or otherwise transferable. The Entitlement Offer is not underwritten. Eligible Shareholders who do not take up their entitlements will not receive any value in respect of those entitlements that they do not take up (and their shareholding in the Company will be diluted). Shareholders who are not eligible to receive entitlements will not receive any value in respect of the entitlements they would have received had they been eligible. No shareholder approval is required for the Entitlement Offer.
Purpose of the Placement and Entitlement Offer and use of funds
BluGlass intends to invest the proceeds of the Placement and Entitlement Offer as follows:
Ongoing research and development of the laser diode product;
Continue product development and testing to expedite delivery of laser diode products in our selected markets;
Investment in sales and marketing channels for successful future laser diode product launch;
Continue investment in our specialist laser diode epitaxy and commercialisation expertise;
Advance development with existing and potential new industry strategic partners, including LED,
microLED and RPCVD market participants;
Reduce operating expenses by developing in-house fabrication processes; and
General working capital to enable ongoing execution of business strategy
Available funds from the Entitlement Offer will also be used by the Company to pay for the costs of the Entitlement Offer.
Download the full announcement here
Download the presentation pack here